Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cytokinetics (CYTK) Consolidated Net Income: 2009-2024

Historic Consolidated Net Income for Cytokinetics (CYTK) over the last 16 years, with Dec 2024 value amounting to -$573.9 million.

  • Cytokinetics' Consolidated Net Income fell 18.95% to -$178.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$602.1 million, marking a year-over-year decrease of 7.41%. This contributed to the annual value of -$573.9 million for FY2024, which is 9.43% down from last year.
  • Cytokinetics' Consolidated Net Income amounted to -$573.9 million in FY2024, which was down 9.43% from -$524.5 million recorded in FY2023.
  • Over the past 5 years, Cytokinetics' Consolidated Net Income peaked at -$109.9 million during FY2020, and registered a low of -$573.9 million during FY2024.
  • Its 3-year average for Consolidated Net Income is -$480.7 million, with a median of -$524.5 million in 2023.
  • Data for Cytokinetics' Consolidated Net Income shows a maximum YoY tumbled of 84.48% (in 2021) over the last 5 years.
  • Cytokinetics' Consolidated Net Income (Yearly) stood at -$109.9 million in 2020, then slumped by 84.48% to -$202.8 million in 2021, then plummeted by 69.48% to -$343.6 million in 2022, then crashed by 52.64% to -$524.5 million in 2023, then dropped by 9.43% to -$573.9 million in 2024.